Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells (2018)
- Autores:
- Autores USP: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; BARBUTO, JOSE ALEXANDRE MARZAGAO - ICB ; PARISE FILHO, ROBERTO - FCF
- Unidades: FCF; ICB
- DOI: 10.2174/1570180815666180321161513
- Assuntos: APOPTOSE; NEOPLASIAS MAMÁRIAS
- Agências de fomento:
- Idioma: Inglês
- Fonte:
- Título do periódico: Letters in Drug Design and Discovery
- ISSN: 1570-1808
- Volume/Número/Paginação/Ano: v. 15, n. 12, p. 1288-1298, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FERNANDES, Thais Batista et al. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, v. 15, n. 12, p. 1288-1298, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570180815666180321161513. Acesso em: 24 set. 2024. -
APA
Fernandes, T. B., Azevedo, R. A. de, Yang, R., Teixeira, S. F., Trossini, G. H. G., Barbuto, J. A. M., et al. (2018). Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, 15( 12), 1288-1298. doi:10.2174/1570180815666180321161513 -
NLM
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 set. 24 ] Available from: https://doi.org/10.2174/1570180815666180321161513 -
Vancouver
Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 set. 24 ] Available from: https://doi.org/10.2174/1570180815666180321161513 - Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells
- Novel capsaicin analogues as potential anticancer agents: synthesis, biological evaluation, and in silico approach
- RPF151, a novel capsaicin-like analogue: in vitro studies and in vivo preclinical antitumor evaluation in a breast cancer model
- Optimization of new dihydrofolate reductase inhibitors of mycobacterium tuberculosis (mtDHFR): molecular docking, synthesis, evaluation of enzyme inhibition and antimycobacterial activity
- Potential candidates for new anticancer agents: synthesis and evaluation of antitumor activity of tioureidics and ureidics analogs of capsaicin
- Planejamento e síntese de análogos bioisostéricos da capsaicina com potencial atividade antitumoral
- Design and synthesis of capsaicin-like sulfonamide analogues as potential antitumor agents
- To be drug or prodrug: structure-property exploratory approach regarding oral bioavailability
- Discovery of a novel capsaicin-like hit against cancer: synthesis, in silico approach and mechanistic studies
- Resenha sem título próprio
Informações sobre o DOI: 10.2174/1570180815666180321161513 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
